Medical Weight Loss with Semaglutide & Tirzepatide Semaglutide and tirzepatide are GLP-1 medications that help regulate appetite, blood sugar, and metabolism, making them one of the most effective medical treatments for weight loss available today
Alongside with his former chief resident and long time friend, cosmetic surgeon Dr
The most common adverse events in the retatrutide groups were gastrointestinal
Get a personalized daily schedule with interaction flags and dosage guidance, built on the same evidence base as this article
In 2025, the company reported a strong +17.08% YoY revenue growth, largely driven by its core therapies: Jardiance ($10.33B) continues to lead as a blockbuster across diabetes, heart failure, and kidney disease, Ofev ($4.49B) remains a key growth driver in pulmonary fibrosis, while Trajenta ($1.72B) continues to contribute despite a mature lifecycle - highlighting a portfolio balancing high-growth and established assets